Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance

Zusammenfassung

Hepatology . Author manuscript; available in PMC: 2019 Apr 1. Published in final edited form as: Hepatology. 2018 Apr;67(4):1560–1599. doi: 10.1002/hep.29800 Search in PMC Search in PubMed View in NLM Catalog Add to search Update on Prevention, Diagnosis, and Treatment and of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance NA Terrault NA Terrault 1 Division of Gastroenterology/Hepatology, University of California San Francisco, San Francisco, CA Find articles by NA Terrault 1 , AS Lok AS Lo

Kerninformationen

ncisco, CA 2 Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI 3 Liver Diseases and Hepatitis Program, Alaska NativeTribal Health Consortium, Anchorage, AK 4 Division of Gastroenterology, Corporal Michael J. Crescenz VA Medical Center & University of Pennsylvania Per...

ecipients. The AASLD 2018 Hepatitis B Guidance provides a data-supported approach to screening, prevention, diagnosis, and clinical management of patients with hepatitis B. It differs from the published 2016 AASLD guideline which conducted systematic reviews and used a multidisciplinary panel of exp...

ed HBV therapies, along with entecavir, tenofovir disoproxil fumarate (TDF), and peginterferon (peg-IFN) ( Tables 1 and 2 ) ( 6 – 16 ) (section: Updated Recommendations on the Treatment of Patients With Chronic Hepatitis B ). Table 1. Approved Antiviral Therapies in Adults and Children Drug Dose in ...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen